Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
about
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenBiochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Bone turnover markers are correlated with total skeletal uptake of 99mTc-methylene diphosphonate (99mTc-MDP).Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives.Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear κB ligand.Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosisEffects of remifemin treatment on bone integrity and remodeling in rats with ovariectomy-induced osteoporosis.Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosisIncreased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice.Effect of teriparatide (rh-PTH 1-34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study.Clinical application of biochemical markers of bone turnover.Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring.Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.Use of bone turnover markers in clinical osteoporosis assessment in women: current issues and future options.A molecular description of acid phosphatase.Biochemical markers of bone turnover - uses and limitations.Biomarkers of cartilage and surrounding joint tissue.Cancellous bone formation response to simulated resistance training during disuse is blunted by concurrent alendronate treatment.Clinical Chemistry and Other Laboratory Tests on Mouse Plasma or Serum.Can elevated serum TRACP-5b levels predict stress fractures? A cohort study.Brief Report: Consecutive Alendronate Administration-Mediated Inhibition of Osteoclasts Improves Long-Term Engraftment Potential and Stress Resistance of HSCs.Comparative pharmacokinetics of two intravenous administration regimens of tiludronate in healthy adult horses and effects on the bone resorption marker CTX-1.Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients.Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.Osteoporosis: Current ConceptsTartrate-resistant acid phosphatase as a biomarker of bone turnover in dog
P2860
Q24242258-816D84DC-5023-4453-B020-6C65E43073BDQ27687777-CE462232-E91A-41A2-B716-0E1C82EBCEABQ33424068-F9AAF539-37E4-4C19-8622-E2617471D357Q33563273-68E5D8EC-A60E-472C-BA35-BF6FC748B76EQ33702810-034A635E-FB1E-4BF5-8C89-8603C630698CQ34585204-F0081175-5707-4D31-922D-FBA5B34A0D41Q35053491-8DE7D8A7-46C6-4B02-9211-CD0F9D033B93Q35070551-40189EB6-1539-4ADD-8425-54A7085D6B44Q35092602-B939C135-9EAB-4EAD-8D0A-CEDAAC2C55BEQ35646110-C10B25AB-57D7-4022-A8E3-0F12A563EF1AQ36340343-E715F1D4-DF7E-49D8-86CA-8787CF2CA31AQ36658915-0D53A29E-9810-4B3E-9BB7-A9C643697678Q37176381-8074A444-CADD-4C06-AB63-BEB6D7CBCF7FQ37729928-CE0D9952-B2C3-4395-9839-B9931DE5CDF0Q37951107-75972AC9-4950-4274-A012-B3D95849068EQ38017593-372A520A-00C3-41ED-9D7E-757D76007934Q38176560-2183CCAF-19F5-4E7C-B3ED-2910A48C3078Q38239828-91C0CFED-4ED0-4B51-9F98-3B209194362FQ38335785-020FBDEC-3BEA-484B-B497-F07C85AFA574Q40841667-C45F8FF9-DB3A-4A56-968B-4D3ED75E6B10Q43135705-3DADB1ED-48AB-4260-AE71-D2CD53A8517AQ46532777-8064C3A5-9813-4EFE-8B40-86F438E2A8B3Q46728028-B574CA31-AD4E-4A41-AAD3-8ABEBE5CB8D4Q46817487-AD9461CF-041C-40A2-A11D-895CF34FC98BQ50936594-2FDDBE16-79F4-4AE6-865B-1DF35F731D09Q56379389-4C075E97-4063-43B4-8EFA-2C277E11CF8DQ57170559-2DE4B16A-30DD-41D3-94A1-0904DAE4BD29
P2860
Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Serum TRACP 5b is a useful mar ...... ther markers of bone turnover.
@en
Serum TRACP 5b is a useful mar ...... ther markers of bone turnover.
@nl
type
label
Serum TRACP 5b is a useful mar ...... ther markers of bone turnover.
@en
Serum TRACP 5b is a useful mar ...... ther markers of bone turnover.
@nl
prefLabel
Serum TRACP 5b is a useful mar ...... ther markers of bone turnover.
@en
Serum TRACP 5b is a useful mar ...... ther markers of bone turnover.
@nl
P2093
P50
P356
P1476
Serum TRACP 5b is a useful mar ...... ther markers of bone turnover.
@en
P2093
Arja Nenonen
H Kalervo Väänänen
Harri Sievänen
Heinrich Schmidt-Gayk
Ilkka Vuori
Jussi M Halleen
Kirsti Uusi-Rasi
Pekka Kannus
Sari L Alatalo
Sulin Cheng
P2860
P304
P356
10.1359/JBMR.050403
P577
2005-10-01T00:00:00Z